Metropolitan Life Insurance Company (MetLife)’s Ouster OUST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1
Closed -$5 2377
2023
Q3
$5 Hold
1
﹤0.01% 2397
2023
Q2
$5 Sell
1
-1,623
-100% -$8.48K ﹤0.01% 2458
2023
Q1
$13.6K Buy
1,624
+614
+61% +$7.12K ﹤0.01% 2052
2022
Q4
$8.71K Buy
+1,010
New +$11K ﹤0.01% 2311
2022
Q3
Sell
-212
Closed -$3.44K 2340
2022
Q2
$3.44K Sell
212
-553
-72% -$15.5K ﹤0.01% 2349
2022
Q1
$34.4K Sell
765
-3,601
-82% -$133K ﹤0.01% 1806
2021
Q4
$227K Buy
+4,366
New +$283K ﹤0.01% 1937
2021
Q3
Sell
-1,041
Closed -$130K 2849
2021
Q2
$130K Buy
+1,041
New +$111K ﹤0.01% 2445

Other funds holding OUST

Metropolitan Life Insurance Company (MetLife)'s OUST Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Ouster (OUST) in Q4 2023, closing a stake of 1 share — an estimated $5 sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in OUST in Q2 2021 and held it in 8 quarters. The position peaked at $227K in Q4 2021. 113 funds tracked by Wall St. Rank hold OUST as of Q4 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Ouster position as of Q4 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1 Ouster share in Q4 2023, an estimated $5.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Ouster in Q2 2021 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Ouster position peaked at $227K in Q4 2021.
  • 113 funds tracked by Wall St. Rank held Ouster as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.